(Q44001051)

English

5-Fluorouracil, interferon-alpha-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Hellenic Co-operative Oncology Group

scientific article published in April 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

5-Fluorouracil, interferon-alpha-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Hellenic Co-operative Oncology Group (English)

1 reference

Europe PubMed Central

28 November 2017

1 reference

based on heuristic

inferred from title

George Fountzilas

3

object named as

G Fountzilas

1 reference

Europe PubMed Central

28 November 2017

author name string

P A Kosmidis

1

1 reference

Europe PubMed Central

28 November 2017

C Bacoyiannis

2

1 reference

Europe PubMed Central

28 November 2017

G Aravantinos

4

1 reference

Europe PubMed Central

28 November 2017

N Tsavaris

5

1 reference

Europe PubMed Central

28 November 2017

C Milathianakis

6

1 reference

Europe PubMed Central

28 November 2017

D Skarlos

7

1 reference

Europe PubMed Central

28 November 2017

publication date

1 April 1997

1 reference

Europe PubMed Central

28 November 2017

Annals of Oncology

1 reference

Europe PubMed Central

28 November 2017

8

1 reference

Europe PubMed Central

28 November 2017

4

1 reference

Europe PubMed Central

28 November 2017

373-378

1 reference

Europe PubMed Central

28 November 2017

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of urothelial tract tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Potentiation of cisplatin by alpha-interferon in advanced non-small cell lung cancer (NSCLC): a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil and recombinant human interferon alfa-2a in the treatment of metastatic chemotherapy-refractory urothelial tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for urothelial tract malignancies: breaking the deadlock

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008287814252

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008287814252

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44001051&oldid=2105454290"